ABO-Incompatible Living Donor Transplantation: Is It Economically “Compatible”?
- 27 July 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (2) , 168-169
- https://doi.org/10.1097/01.tp.0000226242.10027.e7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Complications, Resource Utilization, and Cost of ABO-Incompatible Living Donor Kidney TransplantationTransplantation, 2006
- Transplantation across previously incompatible immunological barriersTransplant International, 2006
- Overcoming Immunologic Incompatibility: Transplanting the Difficult to Transplant PatientSeminars in Dialysis, 2005
- Consequences of Eliminating HLA-B in Deceased Donor Kidney Allocation to Increase Minority TransplantationAmerican Journal of Transplantation, 2005
- Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?Value in Health, 2004
- Cost-Effectiveness of Extending Medicare Coverage of Immunosuppressive Medications to the Life of a Kidney TransplantAmerican Journal of Transplantation, 2004
- ABO Incompatible Transplantation: To B or not to BAmerican Journal of Transplantation, 2004
- The expanded criterial donor dilemma in cadaveric renal transplantationTransplantation, 2003
- Cost-Effectiveness of Repeat Medical ProceduresMedical Decision Making, 1997
- A Cost-effectiveness Analysis of Cyclosporine in Cadaveric Kidney TransplantationMedical Decision Making, 1986